Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAXGN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļAxoGen Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1986
āļāļĩāļāļĩāđāļDale (Michael Donald)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ451
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 17
āļāļĩāđāļāļĒāļđāđ13631 Progress Blvd.
āđāļĄāļ·āļāļALACHUA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ32615
āđāļāļĢāļĻāļąāļāļāđ13864626817
āđāļ§āđāļāđāļāļāđhttps://www.axogeninc.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAXGN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 17, 1986
āļāļĩāļāļĩāđāļDale (Michael Donald)
Mr. Erick Wayne DeVinney
Chief Innovation Officer
Mr. Erick Wayne DeVinney
Chief Innovation Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Independent Director
Mr. Alan M. Levine
Independent Director
Mr. John H. Johnson
Independent Director
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Erick Wayne DeVinney
Chief Innovation Officer
Mr. Erick Wayne DeVinney
Chief Innovation Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board